Ascendis Pharma A/S - ADR
ASND
Market Cap$10.35B
Close$
$158.03
0.9% downside
Current Fair Value
0.9% downsideOvervalued by 0.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $10.35 Billion |
|---|---|
| Enterprise Value | $10.68 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-6.53 |
| Beta | 0.54 |
| Outstanding Shares | 60,018,550 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -26.75 |
|---|---|
| PEG | 68.85 |
| Price to Sales | 31.88 |
| Price to Book Ratio | -39.85 |
| Enterprise Value to Revenue | 32.59 |
| Enterprise Value to EBIT | -32.28 |
| Enterprise Value to Net Income | -26 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | -4.48 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Ascendis Pharma A/S
CEO: Jan Moeller Mikkelsen